Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

First quarter trading update

29 Apr 2025 07:00

RNS Number : 5083G
Elementis PLC
29 April 2025
 

29 April 2025

 

Elementis plc

First quarter trading update

Profit growth with margin improvement in line with expectations; CMD objectives on track.

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues its scheduled trading update for the three months ("the quarter") ended 31 March 2025.

Elementis will publish its interim results for the six months to 30 June 2025 on 31 July 2025.

 

Business performance

 

The Group delivered a solid first quarter performance in a weak global demand environment. While constant currency revenue was down c.2% against a strong prior year comparator, adjusted operating profit and margins were both ahead of Q1 last year, driven by the continued progress of our self-help initiatives, including pricing.

Personal Care sales in the quarter were marginally up on a constant currency basis, compared to the prior year period. Cosmetics was broadly flat despite soft demand in Asia and weaker mix. Profitability and margins were higher compared to Q1 last year on a constant currency basis.

Performance Specialties sales were modestly lower on a constant currency basis compared to Q1 last year, principally due to weaker Coatings demand. Profitability and margins were up compared to Q1 last year on a constant currency basis driven by improved Talc performance.

· Coatings sales decreased in the mid-single digit percentage versus the strong prior year period, due to the weaker demand environment for architectural and industrial coatings, particularly in Asia and EMEA.

· Talc sales were marginally ahead of the comparable period last year.

 

Cash generation in the first quarter was in line with expectations.

 

Talc strategic review

 

The Talc strategic review that was announced in August 2024, continues to progress and we will provide a further update as appropriate.

 

Luc van Ravenstein, CEO of Elementis, said:

"We have delivered a solid performance with growth in profitability and margins in what has been a challenging demand environment. Looking ahead, we are well positioned to manage the potential impacts of the recent US tariffs due to our global multi-site manufacturing footprint. However, the future demand impacts are highly uncertain. To help mitigate this, we are making strong progress with our self-help actions, and are on-track to achieve our target of $12m savings this year, with additional savings opportunities being identified. Whilst we are mindful of the increased economic uncertainty associated with tariffs, our expectations for the full year are unchanged.

We continue to make good progress towards our 2026 goals and are building on our strong foundations to take the business to the next level. I look forward to sharing further details at our interim results."

 

Enquiries

Investors: Zeeshan Maqbool, Elementis plc Tel: +44 7553 340380

Press: Martin Robinson, Giles Kernick, Teneo Tel: +44 (0) 20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWABRVRUSUAR
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.